A Multicenter Phase-Ib/II Study of Ruxolitinib/Pomalidomide Combination Therapy in Patients with Primary and Secondary Myelofibrosis: Safety Data from the Mpnsg-0212 Trial (NCT01644110)
Stegelmann, Frank, Griesshammer, Martin, Reiter, Andreas, Hochhaus, Andreas, Heidel, Florian H, Heiligensetzer, Cora, Sutter, Ulrike, Reim, Regina, Schauer, Stefanie, Kirschbaum, Rebecca, Döhner, Hartmut, Schlenk, Richard F., Döhner, Konstanze
Published in Blood (06.12.2014)
Published in Blood (06.12.2014)
Get full text
Journal Article
A Phase-Ib/II Study of Ruxolitinib Plus Pomalidomide in Myelofibrosis
Stegelmann, Frank, Bangerter, Markus, Heidel, Florian H, Griesshammer, Martin, Hebart, Holger, Hochhaus, Andreas, Koschmieder, Steffen, Möhle, Robert, Reiter, Andreas, Scheid, Christof, Kirschbaum, Rebecca, Reim, Regina, Sutter, Ulrike, Vetter, Katrin, Döhner, Hartmut, Schlenk, Richard F., Döhner, Konstanze
Published in Blood (03.12.2015)
Published in Blood (03.12.2015)
Get full text
Journal Article
Ruxolitinib Plus Pomalidomide in Myelofibrosis: Updated Results from the Mpnsg-0212 Trial (NCT01644110)
Stegelmann, Frank, Hebart, Holger, Bangerter, Markus, Wolleschak, Denise, Griesshammer, Martin, Koschmieder, Steffen, von Bubnoff, Nikolas, Möhle, Robert, Kindler, Thomas, Hochhaus, Andreas, Heidel, Florian H., Reiter, Andreas, Scheid, Christof, Kirschbaum, Rebecca, Reim, Regina, Sutter, Ulrike, Vetter, Katrin, Döhner, Hartmut, Schlenk, Richard F., Döhner, Konstanze
Published in Blood (02.12.2016)
Published in Blood (02.12.2016)
Get full text
Journal Article